Premium
Enzalutamide for treating metastatic hormone‐relapsed prostate cancer before chemotherapy is indicated
Publication year - 2017
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.13936
Subject(s) - enzalutamide , prostate cancer , medicine , nice , oncology , chemotherapy , cancer , computer science , androgen receptor , programming language